RT Journal Article
SR Electronic
T1 Nonlinear relationship between platelet count and 30-day in-hospital mortality in ICU stroke patients: a multicenter retrospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.14.24301300
DO 10.1101/2024.01.14.24301300
A1 Wang, Lan-xiang
A1 Liu, Ren-li
A1 Zhou, Pan
A1 Hu, Hao-fei
A1 Deng, Zhe
YR 2024
UL http://medrxiv.org/content/early/2024/01/16/2024.01.14.24301300.abstract
AB Background Evidence of the relationship between platelet count and 30-day in-hospital mortality in ICU stroke patients is still scarce. Therefore, the purpose of this study was to explore the relationship between platelet count and 30-day in-hospital mortality among ICU stroke patients.Methods We conducted a multicenter retrospective cohort study using data from 8029 ICU stroke patients in the US eICU-CRD v2.0 database from 2014 to 2015. Utilizing binary logistic regression, smooth curve fitting, and subgroup analyses, we examined the link between platelet count and 30-day in-hospital mortality.Results The 30-day in-hospital mortality prevalence was 14.02%, and the mean platelet count of 223×109/L. Adjusting for covariates, our findings revealed an inverse association between platelet count and 30-day in-hospital mortality (OR = 0.975, 95% CI: 0.966, 0.984). Subgroup analyses supported the robustness of these results. Moreover, a nonlinear relationship was observed between platelet count and 30-day in-hospital mortality, with the inflection point at 163×109/L. On the left side of the inflection point, the effect size (OR) was 0.92 (0.89, 0.95), while on the right side, the relationship was not statistically significant.Conclusion This study establishes an independent negative association between platelet count and 30-day in-hospital mortality in ICU stroke patients. Furthermore, a nonlinear relationship with a saturation effect was identified, suggesting that maintaining the platelet count around 163×109/L can reduce 30-day in-hospital mortality in these patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Shenzhen Key Basic Research Project (JCYJ20180228163014668), and Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project (Grant No.20223357005 & No.2023xgyj3357002).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data is accessible to the public after registration, with the collection process meeting the standards of the MIT Ethics Committee (No: 0403000206) and aligning with the 1964 Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe eICU Collaborative Research Database, a freely available multi-center database for critical care research. The data is accessible to the public after registration, with the collection process meeting the standards of the MIT Ethics Committee (No: 0403000206) and aligning with the 1964 Declaration of Helsinki.